CMS Proposes National Noncoverage Of VNS Therapy For Depression
This article was originally published in The Gray Sheet
Executive Summary
CMS plans to reject Cyberonics' request for national Medicare coverage of its VNS therapy for treatment-resistant depression, an action that would also end the firm's ability to seek coverage from local Medicare carriers